February 5, 2025- Thermo Fisher Scientific Inc. announced a 10-year virtual power purchasing agreement (VPPA) with international renewable energy developer X-ELIO designed to increase access to renewable electricity across the pharmaceutical and healthcare supply chains. The Lorca solar project is expected to be operational in early 2026 and includes a cohort of three partners from the pharmaceutical and healthcare sectors.
Thermo Fisher’s share of Lorca solar, together with the Serbal solar project announced in December 2023, will match all of the company’s addressable European sites with 100 percent renewable electricity. The project also accelerates progress toward the company’s goal of achieving 80 percent global renewable electricity by 2030. Thermo Fisher’s 73 MW portion of the Lorca solar project will generate approximately 150,000 megawatt-hours of renewable electricity annually.
Thermo Fisher established its global renewable electricity commitment in 2023, in alignment with the Sustainable Markets Initiative (SMI) Health Systems Task Force joint supplier standards. This followed the company’s raised commitment to reduce Scope 1 and 2 emissions by 50 percent by 2030 against a 2018 baseline, as well as its plans to power all of the company’s U.S. sites with 100 percent renewable electricity by 2026.